Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JD.1.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JD.1.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JD.1.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JD.1.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.43ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.43ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.43EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.43EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.21ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.21ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.21EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JC.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.5.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JC.5.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used